Protagonist Therapeutics (PTGX) Stock Chart & Stock Price History $53.83 0.00 (0.00%) Closing price 08/4/2025 04:00 PM EasternExtended Trading$53.85 +0.02 (+0.04%) As of 08/4/2025 05:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Protagonist Therapeutics Stock Price Performance The Protagonist Therapeutics (PTGX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 50.41%, with a year-to-date return of 39.46%. In the past month, the stock has increased 5.14%, reflecting recent market activity. As of the latest close, Protagonist Therapeutics traded at $53.83 with a market cap of $3.34 billion and volume of 373,998 shares. Five years ago, the stock traded at $16.59, representing a 224.47% increase over that period. At the time, it had a market cap of $448.21 million and a volume of 9,483 shares. Receive PTGX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Protagonist Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.06%1 Month Performance+5.14%3 Month Performance+21.57%Year-To-Date Performance+39.46%1 Year Performance+50.41%5 Year Performance+224.47% PTGX Stock Chart for Tuesday, August, 5, 2025 PTGX Chart by TradingView Protagonist Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/04/2025$53.83$53.83$54.17$52.18373,998 shs$3.34 billion08/01/2025$53.86$53.83-0.06%$55.49$53.60600,772 shs$3.34 billion07/31/2025$54.62$53.86-1.39%$55.29$53.69561,129 shs$3.34 billion07/30/2025$55.01$54.62-0.71%$56.31$54.07388,819 shs$3.39 billion07/29/2025$56.26$55.01-2.22%$57.15$54.53802,688 shs$3.41 billion07/28/2025$55.15$56.26+2.01%$57.10$55.21681,184 shs$3.49 billion07/25/2025$53.74$55.15+2.62%$55.25$53.06490,995 shs$3.42 billion07/24/2025$54.19$53.74-0.83%$54.70$53.56695,927 shs$3.33 billion07/23/2025$54.99$54.19-1.45%$55.02$51.551.31 million shs$3.36 billion07/22/2025$55.22$54.99-0.42%$55.26$54.28680,283 shs$3.41 billion Get the Latest News and Ratings for PTGX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protagonist Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/21/2025$55.48$55.22-0.47%$55.64$54.59441,568 shs$3.42 billion07/18/2025$56.44$55.48-1.70%$56.89$55.15471,125 shs$3.44 billion07/17/2025$56.64$56.44-0.35%$57.73$56.22703,829 shs$3.50 billion07/16/2025$55.32$56.64+2.39%$57.36$55.59614,019 shs$3.51 billion07/15/2025$55.23$55.32+0.16%$55.91$54.54590,063 shs$3.43 billion07/14/2025$53.00$55.23+4.21%$55.41$53.13796,417 shs$3.42 billion07/11/2025$52.83$53.00+0.32%$53.77$52.02752,675 shs$3.28 billion07/10/2025$52.29$52.83+1.03%$52.87$51.28654,941 shs$3.27 billion07/09/2025$49.70$52.29+5.21%$52.35$49.88665,112 shs$3.24 billion07/08/2025$49.87$49.70-0.34%$50.42$49.38591,635 shs$3.08 billion07/07/2025$51.20$49.87-2.60%$51.51$49.51771,742 shs$3.09 billion07/04/2025$51.20$51.20$51.38$49.91339,485 shs$3.17 billion Related Companies Moderna Stock Price Chart Dr. Reddy's Laboratories Stock Price Chart Qiagen Stock Price Chart Viatris Stock Price Chart Ascendis Pharma A/S Stock Price Chart BridgeBio Pharma Stock Price Chart Verona Pharma PLC American Depositary Share Stock Price Chart Blueprint Medicines Stock Price Chart Legend Biotech Stock Price Chart Roivant Sciences Stock Price Chart Receive PTGX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Protagonist Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PTGX) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protagonist Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protagonist Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PTGX Stock Alerts